Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers

Identifieur interne : 000572 ( PascalFrancis/Corpus ); précédent : 000571; suivant : 000573

Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers

Auteurs : Yong-Hua Li ; JIE LI ; Xue-En Liu ; LING WANG ; TONG LI ; Yi-Hua Zhou ; HUI ZHUANG

Source :

RBID : Pascal:06-0005624

Descripteurs français

English descriptors

Abstract

A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0166-0934
A02 01      @0 JVMEDH
A03   1    @0 J. virol. methods
A05       @2 130
A06       @2 1-2
A08 01  1  ENG  @1 Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers
A11 01  1    @1 LI (Yong-Hua)
A11 02  1    @1 JIE LI
A11 03  1    @1 LIU (Xue-En)
A11 04  1    @1 LING WANG
A11 05  1    @1 TONG LI
A11 06  1    @1 ZHOU (Yi-Hua)
A11 07  1    @1 HUI ZHUANG
A14 01      @1 Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road @2 Beijing 100083 @3 CHN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.
A20       @1 45-50
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 18295 @5 354000135504060070
A44       @0 0000 @1 © 2006 INIST-CNRS. All rights reserved.
A45       @0 1 p.1/4
A47 01  1    @0 06-0005624
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of virological methods
A66 01      @0 NLD
C01 01    ENG  @0 A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.
C02 01  X    @0 002A05C09
C03 01  X  FRE  @0 Coronavirus @2 NW @5 01
C03 01  X  ENG  @0 Coronavirus @2 NW @5 01
C03 01  X  SPA  @0 Coronavirus @2 NW @5 01
C03 02  X  FRE  @0 Détection @5 05
C03 02  X  ENG  @0 Detection @5 05
C03 02  X  SPA  @0 Detección @5 05
C03 03  X  FRE  @0 Nucléocapside @5 06
C03 03  X  ENG  @0 Nucleocapsid @5 06
C03 03  X  SPA  @0 Nucleocápside @5 06
C03 04  X  FRE  @0 Protéine @5 07
C03 04  X  ENG  @0 Protein @5 07
C03 04  X  SPA  @0 Proteína @5 07
C03 05  X  FRE  @0 Sérum @5 08
C03 05  X  ENG  @0 Serum @5 08
C03 05  X  SPA  @0 Suero @5 08
C03 06  X  FRE  @0 Microbiologie @5 09
C03 06  X  ENG  @0 Microbiology @5 09
C03 06  X  SPA  @0 Microbiología @5 09
C03 07  X  FRE  @0 Méthode @5 10
C03 07  X  ENG  @0 Method @5 10
C03 07  X  SPA  @0 Método @5 10
C03 08  X  FRE  @0 Virologie @5 11
C03 08  X  ENG  @0 Virology @5 11
C03 08  X  SPA  @0 Virología @5 11
C03 09  X  FRE  @0 Syndrome respiratoire aigu sévère @2 NM @5 14
C03 09  X  ENG  @0 Severe acute respiratory syndrome @2 NM @5 14
C03 09  X  SPA  @0 Síndrome respiratorio agudo severo @2 NM @5 14
C07 01  X  FRE  @0 Coronaviridae @2 NW
C07 01  X  ENG  @0 Coronaviridae @2 NW
C07 01  X  SPA  @0 Coronaviridae @2 NW
C07 02  X  FRE  @0 Nidovirales @2 NW
C07 02  X  ENG  @0 Nidovirales @2 NW
C07 02  X  SPA  @0 Nidovirales @2 NW
C07 03  X  FRE  @0 Virus @2 NW
C07 03  X  ENG  @0 Virus @2 NW
C07 03  X  SPA  @0 Virus @2 NW
C07 04  X  FRE  @0 Virose
C07 04  X  ENG  @0 Viral disease
C07 04  X  SPA  @0 Virosis
C07 05  X  FRE  @0 Infection
C07 05  X  ENG  @0 Infection
C07 05  X  SPA  @0 Infección
N21       @1 002
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 06-0005624 INIST
ET : Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers
AU : LI (Yong-Hua); JIE LI; LIU (Xue-En); LING WANG; TONG LI; ZHOU (Yi-Hua); HUI ZHUANG
AF : Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road/Beijing 100083/Chine (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 6 aut., 7 aut.)
DT : Publication en série; Niveau analytique
SO : Journal of virological methods; ISSN 0166-0934; Coden JVMEDH; Pays-Bas; Da. 2005; Vol. 130; No. 1-2; Pp. 45-50; Bibl. 1 p.1/4
LA : Anglais
EA : A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.
CC : 002A05C09
FD : Coronavirus; Détection; Nucléocapside; Protéine; Sérum; Microbiologie; Méthode; Virologie; Syndrome respiratoire aigu sévère
FG : Coronaviridae; Nidovirales; Virus; Virose; Infection
ED : Coronavirus; Detection; Nucleocapsid; Protein; Serum; Microbiology; Method; Virology; Severe acute respiratory syndrome
EG : Coronaviridae; Nidovirales; Virus; Viral disease; Infection
SD : Coronavirus; Detección; Nucleocápside; Proteína; Suero; Microbiología; Método; Virología; Síndrome respiratorio agudo severo
LO : INIST-18295.354000135504060070
ID : 06-0005624

Links to Exploration step

Pascal:06-0005624

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers</title>
<author>
<name sortKey="Li, Yong Hua" sort="Li, Yong Hua" uniqKey="Li Y" first="Yong-Hua" last="Li">Yong-Hua Li</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jie Li" sort="Jie Li" uniqKey="Jie Li" last="Jie Li">JIE LI</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Liu, Xue En" sort="Liu, Xue En" uniqKey="Liu X" first="Xue-En" last="Liu">Xue-En Liu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ling Wang" sort="Ling Wang" uniqKey="Ling Wang" last="Ling Wang">LING WANG</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tong Li" sort="Tong Li" uniqKey="Tong Li" last="Tong Li">TONG LI</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Yi Hua" sort="Zhou, Yi Hua" uniqKey="Zhou Y" first="Yi-Hua" last="Zhou">Yi-Hua Zhou</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hui Zhuang" sort="Hui Zhuang" uniqKey="Hui Zhuang" last="Hui Zhuang">HUI ZHUANG</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0005624</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0005624 INIST</idno>
<idno type="RBID">Pascal:06-0005624</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000572</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers</title>
<author>
<name sortKey="Li, Yong Hua" sort="Li, Yong Hua" uniqKey="Li Y" first="Yong-Hua" last="Li">Yong-Hua Li</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jie Li" sort="Jie Li" uniqKey="Jie Li" last="Jie Li">JIE LI</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Liu, Xue En" sort="Liu, Xue En" uniqKey="Liu X" first="Xue-En" last="Liu">Xue-En Liu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ling Wang" sort="Ling Wang" uniqKey="Ling Wang" last="Ling Wang">LING WANG</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tong Li" sort="Tong Li" uniqKey="Tong Li" last="Tong Li">TONG LI</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Yi Hua" sort="Zhou, Yi Hua" uniqKey="Zhou Y" first="Yi-Hua" last="Zhou">Yi-Hua Zhou</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hui Zhuang" sort="Hui Zhuang" uniqKey="Hui Zhuang" last="Hui Zhuang">HUI ZHUANG</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of virological methods</title>
<title level="j" type="abbreviated">J. virol. methods</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of virological methods</title>
<title level="j" type="abbreviated">J. virol. methods</title>
<idno type="ISSN">0166-0934</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Coronavirus</term>
<term>Detection</term>
<term>Method</term>
<term>Microbiology</term>
<term>Nucleocapsid</term>
<term>Protein</term>
<term>Serum</term>
<term>Severe acute respiratory syndrome</term>
<term>Virology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Coronavirus</term>
<term>Détection</term>
<term>Nucléocapside</term>
<term>Protéine</term>
<term>Sérum</term>
<term>Microbiologie</term>
<term>Méthode</term>
<term>Virologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0166-0934</s0>
</fA01>
<fA02 i1="01">
<s0>JVMEDH</s0>
</fA02>
<fA03 i2="1">
<s0>J. virol. methods</s0>
</fA03>
<fA05>
<s2>130</s2>
</fA05>
<fA06>
<s2>1-2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>LI (Yong-Hua)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>JIE LI</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>LIU (Xue-En)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>LING WANG</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>TONG LI</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>ZHOU (Yi-Hua)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>HUI ZHUANG</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>45-50</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18295</s2>
<s5>354000135504060070</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>06-0005624</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of virological methods</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05C09</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Détection</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Detection</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Detección</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Nucléocapside</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nucleocapsid</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Nucleocápside</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Protéine</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Protein</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Proteína</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Sérum</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Serum</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Suero</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Microbiologie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Microbiology</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Microbiología</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Méthode</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Method</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Método</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Virologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Virology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Virología</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fN21>
<s1>002</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 06-0005624 INIST</NO>
<ET>Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers</ET>
<AU>LI (Yong-Hua); JIE LI; LIU (Xue-En); LING WANG; TONG LI; ZHOU (Yi-Hua); HUI ZHUANG</AU>
<AF>Department of Microbiology, Peking University Health Science Center, 38 Xueyuan Road/Beijing 100083/Chine (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 6 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of virological methods; ISSN 0166-0934; Coden JVMEDH; Pays-Bas; Da. 2005; Vol. 130; No. 1-2; Pp. 45-50; Bibl. 1 p.1/4</SO>
<LA>Anglais</LA>
<EA>A capture enzyme-enhanced chemiluminescence immunoassay (ECLIA) based on three specific monoclonal antibodies to detect the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in the serial serum samples from SARS patients was developed. The anti-SARS-CoV IgG and the viral RNA were also detected in the sera by ELISA and RT-PCR, respectively. During the first 10 days after onset, anti-SARS-CoV IgG, SARS-CoV RNA and the N protein were detected in 21.4, 42.9, and 90% of the patients' sera, respectively. The detection rate of the N protein during days 11-15 of the disease was still significantly higher than those of anti-SARS-CoV IgG and SARS-CoV RNA. The data demonstrated that detection of the N protein with the capture ECLIA appears to be more useful than detection of other viral makers for rapid diagnosis of SARS in patients.</EA>
<CC>002A05C09</CC>
<FD>Coronavirus; Détection; Nucléocapside; Protéine; Sérum; Microbiologie; Méthode; Virologie; Syndrome respiratoire aigu sévère</FD>
<FG>Coronaviridae; Nidovirales; Virus; Virose; Infection</FG>
<ED>Coronavirus; Detection; Nucleocapsid; Protein; Serum; Microbiology; Method; Virology; Severe acute respiratory syndrome</ED>
<EG>Coronaviridae; Nidovirales; Virus; Viral disease; Infection</EG>
<SD>Coronavirus; Detección; Nucleocápside; Proteína; Suero; Microbiología; Método; Virología; Síndrome respiratorio agudo severo</SD>
<LO>INIST-18295.354000135504060070</LO>
<ID>06-0005624</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000572 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000572 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0005624
   |texte=   Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum : Comparison with results of other viral markers
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021